Tag: Medical Prices

Fact Check on Prescription Drug Coverage

Health plans are committed to assuring that patients have access to high-quality and affordable prescription drug coverage by providing a wide array of plan choices that are designed to meet each individual’s health needs. So as consumers make choices about the type of coverage that works for them, it’s important to keep in mind several important facts. Continue reading

Posted in: Fact Check

Why we need biosimilars

The introduction of biosimilars is sorely needed to bring competition to the biologics space, which includes some of the world’s most expensive medications. Continue reading

Posted in: Issue Alert

2014: A Year in Health Care

To close off 2014, let’s take a look at this year’s most-read posts on the AHIP Coverage blog. The list of top stories shows what health care issues are important to health plans, patients, the media, and policymakers, namely, soaring health care costs and the value of Medicare Advantage coverage. Continue reading

Posted in: In Case You Missed It

Here we go again: Another day, another six-figure drug price

Instead of acknowledging the growing consumer concern and outrage over soaring prices for medical services, media reports today show drugmakers are still turning a blind eye, slapping more six-figure price tags on critical treatments. Continue reading

Posted in: Health Care Costs

The Price Is High and Stays There

The price of tests and scans continue to increase, although the equipment used to perform the procedures has become less expensive. Continue reading

Posted in: Health Care Costs

TEDMED: Tackling the Challenges of Accessibility and Affordability in Health Care

AHIP’s VP for Policy Greg Gierer today joined a group of experts to discuss health care pricing and sustainability. They tackled the question of how to make innovative treatments more accessible to patients while reining in the high cost of care. Continue reading

Posted in: Health Care Costs

Exorbitant drug prices put quality of life and quality of care at risk

The increasing cost of drugs is creating a “financially toxic” cycle that harms the quality of life and quality of care of cancer patients and survivors, according to experts who spoke at the American Society of Hematology’s annual meeting in San Francisco. Continue reading

Posted in: Health Care Costs

Heed the Price Warnings on Provider Consolidation

The growing trend of provider consolidation is expected to continue, which means so too will major medical price increases. With merger mania building up speed, health care leaders, policymakers, and consumers should heed warnings about the dangerous, long-term effects of anticompetitive provider consolidation. Continue reading

Posted in: Health Care Costs

Deep Dive: The Backstory on Sovaldi’s Sky-High Price Tag

A new Vox article gives the story behind Gilead’s $84,000 hepatitis C drug Sovaldi. And the moral of the story is that the sky’s the limit for drug prices in the United States. Continue reading

Posted in: Health Care Costs

Provider consolidation: A lot of evidence and a lot at stake

Provider consolidation sets off a chain reaction that leads to higher prices for consumers, The Journal News reports. Continue reading

Posted in: Health Care Costs